Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease

Rebecca H. Haberman, Ramin Sedaghat Herati, David Simon, Marie Samanovic, Rebecca B. Blank, Michael Tuen, Sergei B. Koralov, Raja Atreya, Koray Tascilar, Joseph R. Allen, Rochelle Castillo, Amber R. Cornelius, Paula Rackoff, Gary Solomon, Samrachana Adhikari, Natalie Azar, Pamela Rosenthal, Peter Izmirly, Jonathan Samuels, Brian Golden, Soumya Reddy, Markus Neurath, Steven B. Abramson, Georg Schett, Mark J. Mulligan, Jose U. Scher
doi: https://doi.org/10.1101/2021.05.11.21256917

Data Availability

All data relevant to the study are included in the article or uploaded as supplementary information. Further de-identified data can be made available upon request. Jose.scher{at}nyulangone.org

Back to top
Posted May 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease
Rebecca H. Haberman, Ramin Sedaghat Herati, David Simon, Marie Samanovic, Rebecca B. Blank, Michael Tuen, Sergei B. Koralov, Raja Atreya, Koray Tascilar, Joseph R. Allen, Rochelle Castillo, Amber R. Cornelius, Paula Rackoff, Gary Solomon, Samrachana Adhikari, Natalie Azar, Pamela Rosenthal, Peter Izmirly, Jonathan Samuels, Brian Golden, Soumya Reddy, Markus Neurath, Steven B. Abramson, Georg Schett, Mark J. Mulligan, Jose U. Scher
medRxiv 2021.05.11.21256917; doi: https://doi.org/10.1101/2021.05.11.21256917
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area